by General
Article from the Frankfurter Allgemeine Zeitung from December 24, 19:
To the newspaper article in the archive of the Frankfurter Allgemeine
01/09/
2020 © All rights reserved. Frankfurter Allgemeine Zeitung GmbH, Frankfurt.
To the newspaper article in the archive of the Frankfurter Allgemeine
2020
MetrioPharm in the FAZ
To the newspaper article in the archive of the Frankfurter Allgemeine
Contact
Eva Brysch
Head of Investor Relations & Corporate Communications
invest@metriopharm.com
Ralf Haubert
Marketing Manager
blog@metriopharm.com
- 08.12.2022 MetrioPharm Announces Topline Data of its Phase IIa Study of MP1032 in COVID-19 Patients
- 12.10.2022 MetrioPharm Starts Preclinical Experiments in Duchenne Muscular Dystrophy (DMD)
- 29.07.2022 Last Patient Out: MetrioPharm Completes Clinical Phase II Trial in COVID-19
- 02.03.2022 MetrioPharm surpasses 50% of enrollment in Phase II study in COVID-19